Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.
CD8(+) T cell responses to vaccinia virus are directed almost exclusively against early gene products. The attenuated strain modified vaccinia virus Ankara (MVA) is under evaluation in clinical trials of new vaccines designed to elicit cellular immune responses against pathogens including Plasmodium...
Main Authors: | Toritse Orubu, Naif Khalaf Alharbi, Teresa Lambe, Sarah C Gilbert, Matthew G Cottingham |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3384612?pdf=render |
Similar Items
-
Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
by: Jarmila Knitlova, et al.
Published: (2014-01-01) -
Poxviral Ankyrin Proteins
by: Michael H. Herbert, et al.
Published: (2015-02-01) -
Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
by: Gareth Betts, et al.
Published: (2012-01-01) -
Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.
by: Naif Khalaf Alharbi, et al.
Published: (2015-01-01) -
Poxviral Strategies to Overcome Host Cell Apoptosis
by: Chathura D. Suraweera, et al.
Published: (2021-12-01)